Company Info
Phone(813) 369-5999
Year Established
2007
Ticker
IOVA
Exchange
NASDAQ
Contacts
Frederick G. Vogt, PhD, Esq.Interim CEO, President & General Counsel
Howard B. Johnson, M.B.A.
CBO
Friedrich Graf Finckenstein, MD
CMO
Igor Bilinsky
COO
Company Description
Iovance Biotherapeutics, Lion Biotechnologies, is focused on the development and commercialization of novel cancer immunotherapies based on tumor infiltrating lymphocytes (TIL).